Literature DB >> 10914950

No response to cladribine in five patients with chronic cold agglutinin disease.

S Berentsen, G E Tjønnfjord, F V Shammas, J Bergheim, J Hammerstrøm, R Langholm, E Ulvestad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10914950     DOI： 10.1034/j.1600-0609.2000.9l201.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  5 in total

1.  Diagnosis and management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the Red Cell Study Group of the Paediatric Haemato-Oncology Italian Association.

Authors:  Saverio Ladogana; Matteo Maruzzi; Piera Samperi; Silverio Perrotta; Giovanni C Del Vecchio; Lucia D Notarangelo; Piero Farruggia; Federico Verzegnassi; Nicoletta Masera; Paola Saracco; Silvia Fasoli; Maurizio Miano; Gabriella Girelli; Wilma Barcellini; Alberto Zanella; Giovanna Russo
Journal:  Blood Transfus       Date:  2016-12-16       Impact factor: 3.443

2.  Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization.

Authors:  Megan Mullins; Xiaohui Jiang; Lauren C Bylsma; Jon P Fryzek; Heidi Reichert; Evan C Chen; Shivaani Kummar; Adam Rosenthal
Journal:  Blood Adv       Date:  2017-05-19

Review 3.  Treatment of autoimmune hemolytic anemias.

Authors:  Alberto Zanella; Wilma Barcellini
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

Review 4.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

Review 5.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.